Crossmark

Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation

Crossref DOI link: https://doi.org/10.1186/s12906-024-04497-z

Published Online: 2024-05-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Xingyun

Ren, Yanling

Qin, Shuanglin

Yang, Zerui
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82304657)
License Information

Text and Data Mining valid from 2024-05-23

Version of Record valid from 2024-05-23
More Information

Article History

Received: 26 January 2024

Accepted: 10 May 2024

First Online: 23 May 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below